Intra-Cellular Therapies Inc. is a biopharmaceutical company focused on the development of innovative treatments for neurological and psychiatric disorders. With a strong pipeline of promising therapies, the company is dedicated to improving the lives of patients suffering from conditions such as schizophrenia and major depressive disorder.